tirzepatide lose weight freeze-dried powder white raw powder
TDS
14542-15-5
Pharmaceutical Grade
99.55%
Hongkong
Luckypeptide
5/10/15/20/30/40/50/60/80 mg Vials/Bottle/Bag/Catron
2028-01-07
Retatrutide,Tirzepatide,Semaglutide,Reta,GLP-1,Klow
-
Product Description
-
Seller Information
-
DescriptionCertificates
-
TDS
Basic Info-
Product Name:
Methyl 4-methylthiazole-2-carboxylate
Other Name:methyl 4-methyl-1,3-thiazole-2-carboxylate; 4-Methyl-2-thiazolecarboxylic acid methyl ester;
CAS No.:14542-15-5
Molecular Formula:C6H7NO2S
InChIKeys:QYBUZTKTDPPXJR-UHFFFAOYSA-N
Molecular Weight:157.19000
Exact Mass:157.01974964
DSSTox ID:DTXSID40465699
Categories:
Characteristics-
PSA:
67.43000
XLogP3:1.23810
Density:1.245g/cm3
Boiling Point:233.933ºC
Refractive Index:1.535
Vapor Pressure:0.054mmHg at 25°C
Research-
Class:
Dual agonist — GIPR, GLP-1R
Status:FDA-approved (Mounjaro / Zepbound)
Mechanism:Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.
EC50 (Human GLP1R):0.934 nM
EC50 (Human GIPR):0.0224 nM
Source:Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI
Clinical Development:NCT03954834; NCT03987919; NCT03882970; NCT03730662; NCT04039503
FDA:Mounjaro, Zepbound (approved 2022-05-13)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Disclaimer:
Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Retatrutide,Tirzepatide,Semaglutide,Reta,GLP-1,Klow
-
Location:
RM 102, 1/F, THE CLOUD, 111 TUNG CHAU STREET, TAI KOK TSUI HONG KONG
-
Average lead Time:
12
-
Total Annual Revenue:
Less than $1 million
-
Total Employees:
Less than 5
-
Year of Establishment:
2025
-
Certifications:
Semaglutide COA,Epitalon COA,Tirzepatide COA,Retatrutide 10mg,Glutathione COA,Mots-c 10mg,Ipamorelin COA
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product